Haryana Man Becomes First In India To Receive Covid-19 Cocktail Drug Once Administered To Trump swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
ROHTAK: The condition of Haryana Health Minister Anil Vij, who is undergoing treatment for COVID-19 at the Medanta Hospital in Gurugram, is stable and his vitals parameters are normal, Dr AK Dubey, Medical Superintendent, of the hospital on Thursday. Haryana Health Minister is undergoing treatment at the intensive care unit (ICU) ward of Medanta hospital in Gurgaon. His health condition is stable and his vitals parameters are normal, Dubey said.
Vij, who had tested positive for coronavirus after taking a trial dose of Bharat Biotech s COVID-19 vaccine Covaxin was recently referred to Medanta Hospital Gurugram.A team of doctors from Medanta had reached Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) Rohtak for the treatment of the Haryana Minister.
COVID-19 positive Anil Vij referred to Medanta Hospital in Gurugram from PGI Rohtak ANI | Updated: Dec 15, 2020 19:12 IST
Rohtak (Haryana) [India], December 15 (ANI): Haryana Health Minister Anil Vij, who had tested positive for coronavirus after taking a trial dose of Bharat Biotech s COVID-19 vaccine Covaxin has been referred to Medanta Hospital Gurugram on Tuesday.
Earlier in the day, a team of doctors from Medanta had reached Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) Rohtak for the treatment of Vij.
While talking to media, Bharatiya Janata Party (BJP) state president, Om Prakash Dhankar said, I have talked to him, he is well. He is feeling fine. Medicines are being given to him. He will be among us soon.
COVID positive Anil Vij referred to Medanta from PGI Rohtak bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.